Laman UtamaPTCT • NASDAQ
add
PTC Therapeutics, Inc.
Tutup sebelumnya
$49.52
Julat hari
$49.03 - $50.43
Julat tahun
$28.72 - $58.38
Permodalan pasaran
3.98B USD
Bilangan Purata
1.12J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 213.17J | -30.58% |
Perbelanjaan pengendalian | 87.99J | -42.66% |
Pendapatan bersih | -65.89J | 57.71% |
Margin untung bersih | -30.91 | 39.08% |
Pendapatan bagi setiap syer | -0.34 | -17.15% |
EBITDA | -9.11J | -110.86% |
Kadar cukai berkesan | 30.43% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.15B | 30.66% |
Jumlah aset | 1.71B | -10.06% |
Jumlah liabiliti | 2.80B | 3.27% |
Jumlah ekuiti | -1.10B | — |
Syer tertunggak | 78.87J | — |
Harga kepada buku | -3.50 | — |
Pulangan pada aset | -2.24% | — |
Pulangan pada modal | -2.83% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -65.89J | 57.71% |
Tunai daripada operasi | -30.00J | 70.08% |
Tunai daripada pelaburan | 267.71J | 383.54% |
Tunai daripada pembiayaan | 26.47J | -95.73% |
Perubahan bersih dalam tunai | 255.53J | -40.42% |
Aliran tunai bebas | 146.12K | 100.56% |
Perihal
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
Diasaskan
1 Jan 1998
Ibu pejabat
Tapak web
Pekerja
939
